Introduction
Vasculitis is a feature of many different diseases and syndromes of childhood.! In some it is the predominant manifestation of the condition but in others may reflect one aspect of a more widespread connective tissue disorder.s-' As a result, classification has proved difficult and is not entirely satisfactory. One classification that has proved useful, based on that of Fink," is outlined in Table 1 .
it appears to be a recognizable distinct entity. Over the past 25 years at least 36 children with 'classic' polyarteritis nodosa have been seen at the Hospital for Sick Children, London, their average age being eight years (range 17 days to 15 years) with a male/female ratio of 1.6:1. Inmany children 
Macroscopic polyarteritis (polyarteritis nodosa)
This is the form of polyarteritis in which necrotizing vasculitis is associated with aneurysmal nodules along the walls of medium-sized arteries; it is akin to the disease described by Kussmaul and Maier in 1866,5 Typically it is a disease of adults in middle life but it can and does occur in childhood.e-e There may, as reported in adults, be some overlap with smaller vessel disease but the diagnosis was not obvious on initial presentation, with infective, 'rheumatic', and malignant diseases being considered before the true nature of the condition was revealed.
Clinical manifestations
The main clinical manifestations are malaise, fever, skin rash, abdominal pain and arthropathy.3.6-13 Myalgia, ischaemic heart pain, testicular pain, renal manifestations such as haematuria and hypertension, neurological features such as focal deficits, hemiplegia, visual loss, mononeuritis multiplex and organic psychoses are also observed. Skin lesions are variable and may be similar to those of Henoch-Schonlein purpura or erythema multiforme, but at times are necrotic and can be associated with peripheral gangrene. In the Great Ormond Street patients the percentage system involvement was as follows: renal 63%, cardiac 26%, neurological 26%, respiratory 21% and gut 15% (although the amount of abdominal pain suggested that the gut was more frequently affected). 13
Laboratory and radiological investigations
In the active phase of the disease anaemia, polymorphonuclear leucocytosis, thrombocytosis, increased erythrocyte sedimentation rate and Creactive protein are seen. 3.6-9.11-13 Circulating immune complexes have been reported coupled with platelet aggregating material in plasma.14 The plasma of patients with active disease has, at times, a greenish tinge, due to a copper-containing, possibly caeruloplasmin-like, acute reactant that disappears in remission. Antineutrophil cytoplasm antibodies (ANCA) may be detected in certain forms of polyarteritis.Pv" most characteristically in the microscopic variety that presents with rapidly progressive glomerulonephritis. However, although in the macroscopic form of the disease ANCA were usually considered to be absent, evidence is accumulating that ANCA with either cytoplasmic staining (c-ANCA) on indirect immunofluorescence or a perinuclear pattern of staining (p-ANCA) are occasionally seen. 17 To confirm the diagnosis it is necessary to demonstrate involvement of medium-sized arteries. Two-dimensional echocardiography may confirm coronary artery involvement but, in general, medium-sized muscular artery disease is best demonstrated by renal and hepatic angiography. 12.13.18.19 Patchy renal ischaemia shown on 99mTc-labelled dimercaptosuccinic acid (DMSA) scanning can provide indirect evidence of vessel occlusion or severe narrowing.P
The diagnosis can also be confirmed morphologically within affected tissue. Muscle biopsy material has been used, but sampling from an informative area often proves difficult.s? Skin biopsy may also reveal vasculitic changes if there is obvious skin involvement at the time the child is being evaluated. Characteristic histopathological changes on renal biopsy may be seen if appropriate vessels such as arcuate or interlobular arteries are sampled. However, such biopsies carry risks of bleeding and the formation of arteriovenous fistulae.u Fibrinoid necrosis with a marked inflammatory response within and surrounding the vessel plus or minus destruction of the internal elastic lamina are the hallmarks of the histological picture.P Aneurysms may be observed, as well as ischaemic changes with occasional areas of infarction. The presence of focal necrotizing or crescentic glomerulonephritis indicates some smaller vessel involvement.
Treatment and prognosis
The usual recommended treatment includes oral steroidt-? and cyclophosphamide.as.z-Some advocate pulsed intravenous injections of cyclophosphamide.P although the evidence that this is more effective and less prone to complications than oral administration is not that secure.w In addition, antiplatelet therapy such as dipyridamole seems appropriate, in view of the platelet hyperaggregability and vascular endothelial damage. Plasma exchange has a role in life-threatening situations,27.28 and, akin to its use in Kawasaki disease, prostacyclin (PGI 2) has been administered when major ischaemic complications seem imminent.w High-dose intravenous gamma-globulin has also been utilized following the demonstration of its efficacy in Kawasaki disease. 30 However, its therapeutic value remains to be seen. Azathioprine and cyclosporin A appear to be helpful in maintaining remission with steroids, hence avoiding the problems of long-term cyclophosphamide therapy,13 but do not appear to be effective in inducing remission.
Prognosis is variable but there is a significant mortality (21% in the Great Ormond Street series) .12.13 Renal involvement, although not necessarily the cause of death, was a feature in all those who died and was a poor prognostic finding. In other series of childhood polyarteritis the outcome has been substantially better and some questions must be raised as to the precise categorization of the affected children.e-s In contrast, Fink? described eight children treated between 1959 and 1974 with a mortality of 37% and fiveyear mortality in adults varies from 18-37%.24.31
Microscopic polyarteritis
Microscopic polyarteritis was first distinguished from classic polyarteritis nodosa by the observation of extensive glomerular disease.F It differs from Wegener's granulomatosis by the absence of granulomas and the rarity of upper airway involvement although it has many features in common due to necrotizing inflammation of small vessels. It has been defined as small vessel vasculitis with focal segmental necrotizing glomerulonephritis, but without granulomatous disease of the respiratory tract.P It has been considered that idiopathic focal necrotizing and crescentic glomerulonephritis without anti-GBM (glomerular basement membrane) antibodies is a renal limited form of vasculitis ,34-37 and indeed it seems likely that this and microscopic polyarteritis are the same condition.V In spite of this there is evidence that some patients do also manifest some extrarenal features. 38 In adults it tends to be a disease of middle-aged men, but it also occurs in childhood, usually presenting as rapidly progressive glomerulonephritis with crescent formation seen histologically.w-"
Clinical features
These are the result of widespread small vessel vasculitis. The kidneys are invariably involved with proteinuria, haematuria, casts and renal impairment. Hypertension may be a prominent feature,26.33.42 and involvement of joint, muscles, eyes, skin, gut, nervous system and lungs may occur. 33.38.42,43 Laboratory and radiological investigations
The diagnosis of microscopic polyarteritis depends on the demonstration of small vessel vasculitis affecting the kidneys and at least one other organ system in the absence of typical clinical, radiological or histological evidence of necrotizing granulomata.v There will also, in the majority of patients, be evidence of anaemia, leucocytosis, thrombocytosis, elevation of ESR (erythrocyte sedimentation rate) and C-reactive protein, evidence of renal impairment, proteinuria, macroscopic or microscopic haematuria, granular and red cell casts, hyperglobulinaemia, immune complexes in circulation and, at times, positive rheumatoid factors. 38 In microscopic polyarteritis ANCA have been described although the findings are heterogeneous.v' Characteristically there is a p-ANCA pattern on indirect immunofluorescence with the antibodies directed against neutrophil granule myeloperoxidase,16,45-47 but a c-ANCA appearance is occasionally recorded and at times combinations of these patterns are found. 38 A subgroup of patients with nephritis, severe lung haemorrhage and IgM class ANCA has been reported.w but it appears that similar patients may also have IgG antibodies against myeloperoxidase.s? The p-ANCA pattern and the presence of antimyeloperoxidase antibodies on ELISA (enzyme-linked immunosorbent assay) point to a non-Wegener's form of vasculitis and can be helpful in making this diagnostic distinction.
Alveolar haemorrhage and occasionally pleural effusions may be seen on chest X-rays. Angiography is not usually helpful unless there is an overlap with larger vessel disease. The definitive diagnosis requires histological confirmation by renal biopsy which shows focal necrotizing glomerulonephritis with crescent formation. Immunofluorescence shows scanty or absent immunoglobulin deposition.
Treatment and prognosis
Initial therapy usually involves oral corticosteroids such as prednisolone, to which is added cyclophosphamide by mouth, although some advocate azathioprine. 26.33,41,42 Intermittent pulsed intravenous cyclophosphamide has been recommended.s? but its benefit is still unproven and there seems to be no clear therapeutic advantage over oral therapy.26,5o Pulsed methylprednisolones! ,52 and plasma exchange have also been utilized for aggressive rapidly progressive glomerulonephritis,41,53 especially if dialysis dependent or in those facing life-threatening complications. The addition of some form of antiplatelet therapy would seem prudent and dipyridamole is often used in this context. Gradual reduction of treatment after an initial aggressive course is recommended with a change from cyclophosphamide to azathioprine. Therapy is often required for a number of years and although it can be discontinued it is important to continue to monitor the patient in the long term to identify a relapse early should it occur.
Data concerning long-term survival in children are limited, but from the adult literature actuarial survival at five years it is of the order of 64%. 38, 42 Overall actuarial renal survival amongst adults was 50% at five years in the Hammersmith Hospital series. 38
Kawasaki disease (mucocutaneous lymph node syndrome)
This childhood systemic vasculitis was first described in Japan in 1967. 54 Since then over 80 000 cases have been reported from that country alone,55 although it is of worldwide distribution, affecting predominantly infants and young children under five years of age. 29 There is an ethnic bias towards Oriental or Afro-Caribbean children, a male preponderance, some seasonality, and occasional epidemics. 56,57
Clinical features
The principal manifestations are outlined in Table 2 , based on the diagnostic guidelines prepared by the Japan Kawasaki Disease Research Table 3 .
Incidence
In Japanese populations the incidence is 150 per 100 000 children less than five years of age per year. 55 Elsewhere the incidence is substantially less: 10.3 (USA), 2.9 (Germany) and 1.5 (UK) per 100 000 children less than five years of age. 60, 61 
Cardiovascular complications
Cardiovascular complications are variable but may be up to 35% if transient coronary artery dilatation, pericardial effusion, ECG abnormalities, pericarditis, myocardial infarction, ventricular aneurysm, mitral incompetence and cardiac failure are included. 29,57,62,63 The incidence of coronary artery aneurysm ranges from 20 to 30% depending on which series is being considered. Mortality is of the order of 1-2% although this is decreasing since the introduction of immunoglobulin therapy. 
Laboratory investigations
Investigations reveal a polymorphonuclear leucocytosis, thrombocythaemia, circulating immune complexestand both antineutrophil cytoplasmic antibodiess" (ANCA) and anti-endothelial cell antibodies 65,66 (AECA) which may have diagnostic as well as aetiopathological roles. The ANCA findings on immunofluorescence are very characteristic, with a diffuse cytoplasmic staining that is distinct from the granular cytoplasmic pattern seen in Wegener's granulomatosis or the perinuclear pattern in renal associated disease.s"
Treatment
Aspirin and high-dose intravenous gammaglobulin either as five daily doses of 400 mg/kg/ day,68 or one dose of 2 g/kg,69 are currently recommended. Dipyridamole has also been used in addition to aspirin by some groups. In the presence of very large coronary artery aneurysms, especially if there is myocardial ischaemia, intravenous prostacyclin-? or plasma exchange or exchange transfusions-" may also have a place. Intraarterial or intravenous urokinase has been used when a coronary artery becomes occluded with thrombus.?? Coronary revascularization surgery may be indicated for critical stenotic lesions in the convalescent phase of the illness."! Steroids remain controversial and are not advocated, but some argue that they might have a role if used in conjunction with aspirin therapy. In support of this is the observation that steroid treatment has been of value in children at the Hospital for Sick Children with aggressive disease who appear resistant to gamma-globulin and aspirin therapy.
Prognosis
The general outlook for children with Kawasaki disease is good although there is an acute mortality rate of 1-2% due to myocardial infarction. This may be reduced by alertness of clinicians to the diagnosis, and the early use of gamma-globulin and antiplatelet therapy. After the acute phase there is morbidity and occasionally mortality due to coronary artery stenotic lesions in later life 72 with ischaemic myocardial sequelae. It has interestingly been postulated that adult atheromatous coronary heart disease may have its origins in childhood and be due to previous covert or overt Kawasaki disease.P
Wegener's granulomatosis
Wegener's granulomatosist-is a necrotizing granulomatous vasculitis of the upper and lower respiratory tract, with glomerulonephritis and a degree of systemic small vessel vasculitis.P It can occur as a systemic disorder or be limited, at least in the first instance, to one or two organ systems.?« It is rare in childhood but has been reported, 13, 77, 78 The identification of ANCA in patients with Wegener's granulomatosis has recently opened up a means of diagnosis for the condition and, in addition, an opportunity to monitor disease activity subsequent to commencing treatment. 44, 79, 80 Clinical and laboratory findings Clinical features are similar to those seen in polyarteritis nodosa. There are, however, particular features that point to a diagnosis of Wegener's granulomatosis even without the serological help provided by ANCA assays. Seven children have recently been seen at the Hospital for Sick Children 13,81 and in four the predominant presenting feature was subglottic stenosis due to granulomatous involvement of the trachea requiring tracheostomy, Opaque paranasal sinuses, nasal septum destruction with saddle nose and epistaxis were also seen. Similar features are seen in relapsing polychondritis,82 which is even less common in children but can occur and needs to be borne in mind. Aggressive crescentic glomerulonephritis is seen in some children but this is not a prerequisite for the diagnosis. The serum from the majority of patients contains circulating ANCA with the characteristic granular cytoplasmic distribution seen by indirect immunofluorescence, The antibody is directed against the alpha-granule component, proteinase 3. 83
Treatment and prognosis
Treatment essentially consists of steroids, cyclophosphamide by mouth or by pulsed intravenous injection, antiplatelet medication, antimicrobials such as co-trimoxazole, and plasma exchange in life-threatening situations. 38,84-86 Most patients need long-term steroid and immunosuppressive agents and in some children, once remission has been induced with cyclophosphamide, it is possible to maintain it on a combination of steroid and azathioprine or steroid and cyclosporin A. 13, 38, 87 Of the seven Great Ormond Street patients, six have survived but remain on treatment. The child who died was a three-month-old baby whose localized subglottic stenotic disease evolved into a widespread systemic vasculitis. 13 ,81 
Churg-Strauss syndrome
Churg-Strauss syndrome or allergic granulomatosis is extremely rare in childhood. 8 &-90 The clinical picture consists of variable vasculitic manifestations associated with asthma and eosinophilia.w For the diagnosis to be established it was considered that histopathologically necrotizing vasculitis, eosinophilic tissue infiltration and extravascular granulomata had to be present. Some now feel that it is impractical to insist on the demonstration of granulomata to confirm the diagnosis. 90 
Clinical and laboratory findings
A history of asthma with eosinophilia and infiltrates seen on the chest X-ray is suggestive if associated with vasculitis. The latter may be a leucocytoclastic skin vasculitis, but coronary, gut and renal vessels may also be affected by the vasculitic process, although the kidney is infrequently lnvolved.v! Granulomatous pericarditis and mononeuritis multiplex have been reported. ANCA may be demonstrable and may show either a perinuclear or a cytoplasmic form on indirect immunofluorescence staining.Ps Churg-Strauss syndrome may be difficult to differentiate from other forms of vasculitis and it is clear that clinically it may overlap several vasculitic disorders."
Treatment and prognosis
Steroids are the mainstay of therapy but cytotoxic agents may need to be added.vi Cyclophosphamide is the preferred agent should this be necessary.w In adults, it is usually possible to limit duration and gradually reduce or withdraw treatment in time but the limited available data make it difficult to prognosticate in childhood. The literature, however, certainly suggests that there is not an inconsequential mortality and hence the outlook must remain guarded.
Henoch-Schonlein purpura (anaphylactoid purpura)
Henoch-Schonlein purpura or anaphylactoid purpura is the commonest form of childhood systemic vasculitis and is an example of leucocytoclastic vasculitis involving small vessels most obviously in the skin. 94 ,95 Within this category there is frequently an initiating agent that might be a drug or a microorganism, hence the alternative terms allergic or hypersensitivity vasculitis have been used to describe this type of disorder. Henoch-Schonlein purpura is essentially a disease of childhood, occurring more commonly in males, frequently preceded by an upper respiratory infection and with more cases occurring in the winter months. 96 ,97 
Clinical features
The main features are nonthrombocytopenic palpable purpura, arthritis or arthralgia, abdominal pain, gut haemorrhage and glomerulonephritis. The purpura occurs on dependent and presssure-bearing areas often involving the lower limbs and buttocks but in young children it may also affect the face. Subcutaneous oedema is also prominent in children under two years of age.
Glomerulonephritis is seen in 50% of affected children and in approximately 10% of these its manifestations are serious. 98 ,99 The spectrum of renal disease varies from microscopic haematuria to severe nephritic/nephrotic syndrome and renal failure.
Laboratory investigations
There are no specific diagnostic laboratory tests. Most children manifest a moderate leucocytosis and in some there may be a thrombocytosis. Thrombocytopenia would raise diagnostic questions. Serum IgAl00 and IgM are increased in half of the patients and circulating IgA-containing immune complexes-''! and cryoglobulins may be present. IgA ANCA have now been demonstrated in some patients with Henoch-Schonlein purpura. 102 Haematuria and proteinuria are frequently found. Evidence of impairment of renal function, with or without hypertension but in the presence of nephrotic-range proteinuria, justifies a renal biopsy. This may reveal proliferative glomerulonephritis with a range of severity from focal, segmental lesions to an extensive, crescentic form. Immunofluorescence reveals the presence of mesangial IgA deposits and, in some cases, the complement component C3, fibrin, and IgM.
Treatment and prognosis
Treatment is generally supportive. Corticosteroids given over a few weeks may help severe gut disease. Steroids are not thought to have a role in the treatment of renal disease, except for aggressive, rapidly progressive glomerulonephritis, where steroids, immunosuppressives such as cyclophosphamide, and antiplatelet therapy have a place. In the acute stage some advocate pulsed treatment with methylprednisolone and/or plasmapheresis.
The prognosis is usually excellent. There are, however, important complications and occasional deaths associated with gut and kidney disease.P> Overall, 5% of children with Henoch-Schonlein purpura progress to end-stage renal failure and account for approximately 10% of renal failure from all causes in children. Renal transplantation is possible and successful in such patients; recurrence in the graft is rare.
Hypersensitivity angiitis
The commonest small vessel vasculitis that masquerades as Henoch-Schonlein purpura is undoubtedly some form of hypersensitivity vasculitis, usually drug-induced, but at times associated with other antigens, often infectious agents.l03. 104 The salient clinical features of hypersensitivity vasculitis have been clearly outlined by Fauci et a/. 105 Although seemingly involving the skin with palpable nodules or purpura, other organs can be affected and at times the condition appears to evolve into one of the systemic necrotizing vasculitides. Characteristically, the vascular lesions involve arterioles, capillaries and particularly venules.tw In drug-induced disease there may be a prominent and characteristic mononulear cell infiltratelw in contrast to the polymorphonuclear leucocyte infiltrate that is common in Henoch-Schonlein disease. Removal of the offending agent is usually followed by resolution of the clinical features. In others, steroid may be indicated. Occasionally evidence supporting a streptococcal aetiology has resulted in benefit from prophylactic penicillin therapy.s
'Rheumatic' vasculitis
In a number of 'rheumatic' diseases a vasculitic picture can be seen at times but is not the predominant feature. Vasculitis is seen in systemic lupus erythematosus, juvenile chronic arthritis, mixed connective tissue disease, dermatomyositis and scleroderma, but the overriding clinical and pathological features are not vasculitic in nature. In view of this these disorders will not be dealt with in this review.
Giant cell arteritis
Giant cell arteritis, also known as Takayasu disease, is a segmental inflammatory vasculitis causing stenosis and aneurysms of large muscular arteries, especially the aorta or its major branches.P? It is probably the third commonest vasculitis of childhood after Henoch-Schonlein purpura and Kawasaki disease if considered worldwide, although it is relatively uncommon in Europe and North America. [108] [109] [110] [111] [112] It is well recognized in Africa, Asia and Latin America. Its cause is unclear but there may be genetic factors and there is a possible role for tuberculosis in its pathogenesis. 109, 110 Clinical and laboratory findings Early manifestations of the disease include fever, night sweats, anorexia, weight loss and arthritis.P? Later features of hypertension, congestive cardiac failure and evident pulse deficits may be the clues to the underlying cause of a hitherto puzzling illness. 109 • 11l , ll2 Investigations will reveal an increase in the ESR and other acute-phase reactants. Weakly positive tests for antinuclear antibodies and rheumatoid factors may be found as well as anti-aorta antibodies.U' Widening and calcification of the aorta may be found on plain X-ray. Doppler ultrasonography may demonstrate blood flow abnormalities, but for an anatomical diagnosis magnetic resonance angiography or standard aortography are required. 114 , 1l5
Treatment and prognosis
There is no consensus on the management of Takayasu's arteritis. Some advocate corticosteroid therapy in the acute phase 109 and if unresponsive other immunosuppressive agents such as cyclophosphamide.tw A positive tuberculin test may be an indication for antituberculous therapy. Hypotensive agents and antiplatelet therapy also have a place. Reconstructive surgery and transluminal angioplasty have been helpful in older children with inactive disease.u? It is difficult to predict the outcome or the response to treatment in patients who present with Takayasu's arteritis in childhood in view of the limited data in the literature.
